{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:01:29Z","timestamp":1790701289603,"version":"4.1.0"},"reference-count":70,"publisher":"IMR Press","issue":"9","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Background: Most human tumors maintain telomeres through telomerase activation; however, a subset relies on the telomerase-independent mechanism known as Alternative Lengthening of Telomeres (ALT). ALT-positive tumors are frequently characterized by inactivating alterations in ATRX (Alpha Thalassemia\/Mental Retardation Syndrome X-linked) and p53 and by distinct molecular and cellular features. Although chronic telomeric replication stress has been proposed as a trigger for ALT, several aspects of this process remain poorly understood. Recent evidence suggests that ATRX depletion promotes the persistence of DNA secondary structures, including G-quadruplexes (G4), which can impair replication fork progression, leading to fork stalling and DNA damage. Methods: To investigate whether ATRX and p53 deficiency sensitize telomerase-positive cells to develop ALT-associated molecular features in response to telomeric replication stress, we analyzed telomeric DNA damage, telomere sister chromatid exchange (T-SCE), Telomeric Repeat-containing RNA (TERRA) expression, and C-circle formation in HCT116 cells proficient or deficient for ATRX and p53. ATRX was depleted using both transient (siRNA-mediated knockdown) and stable (shRNA-expressing clones) approaches, allowing us to distinguish the early cellular response from the features arising upon persistent ATRX loss. To further assess the contribution of telomeric replication stress, cells were treated with the G4-stabilizing ligand RHPS4. Results: Our data show that G4 stabilization, in the context of ATRX and\/or p53 deficiency, promotes the appearance of multiple ALT-associated hallmarks, including telomeric DNA damage, increased T-SCE, and elevated TERRA expression. Moreover, the combined loss of ATRX and p53 permits cell-cycle progression despite the presence of RHPS4-induced telomeric replication stress and telomeric DNA damage. Conclusions: These findings clarify how ATRX and p53 loss, even in telomerase-positive cells, are permissive conditions for the emergence of ALT-associated hallmarks under telomeric replication stress and highlight the G2\/M checkpoint as a critical barrier limiting the propagation of cells displaying these features.<\/jats:p>","DOI":"10.31083\/fbl52954","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:21:51Z","timestamp":1790698911000},"source":"Crossref","is-referenced-by-count":0,"title":["Telomeric Replication Stress Promotes ALT-Associated Hallmarks in ATRX- and p53-Deficient Cells"],"prefix":"10.31083","volume":"31","author":[{"given":"Roberta","family":"Amato","sequence":"first","affiliation":[{"name":"Department of Science, University \u201cRoma Tre\u201d, 00146 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Micheli","sequence":"additional","affiliation":[{"name":"Department of Science, University \u201cRoma Tre\u201d, 00146 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Focaccetti","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Translational Medicine, Faculty of Medicine and Surgery, University of Rome \u201cTor Vergata\u201d, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Bei","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences and Translational Medicine, Faculty of Medicine and Surgery, University of Rome \u201cTor Vergata\u201d, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiorgio","family":"La Rosa","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Section of Human Anatomy, Catholic University of the Sacred Heart, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6757-8931","authenticated-orcid":true,"given":"Antonella","family":"Sgura","sequence":"additional","affiliation":[{"name":"Department of Science, University \u201cRoma Tre\u201d, 00146 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3094-4139","authenticated-orcid":true,"given":"Francesco","family":"Berardinelli","sequence":"additional","affiliation":[{"name":"Department of Science, University \u201cRoma Tre\u201d, 00146 Rome, Italy"},{"name":"Laboratory of Neurodevelopment, Neurogenetics and Molecular Neurobiology Unit, IRCCS Santa Lucia Foundation, 00179 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Blackburn EH. Telomere states and cell fates. Nature. 2000; 408: 53\u201356.","DOI":"10.1038\/35040500"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes & Development. 2005; 19: 2100\u20132110.","DOI":"10.1101\/gad.1346005"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Greider CW, Blackburn EH. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell. 1985; 43: 405\u2013413.","DOI":"10.1016\/0092-8674(85)90170-9"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature. 1990; 345: 458\u2013460.","DOI":"10.1038\/345458a0"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Artandi SE, DePinho RA. Telomeres and telomerase in cancer. Carcinogenesis. 2010; 31: 9\u201318.","DOI":"10.1093\/carcin\/bgp268"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Kim SH, Beausejour C, Davalos AR, Kaminker P, Heo SJ, Campisi J. TIN2 mediates functions of TRF2 at human telomeres. The Journal of Biological Chemistry. 2004; 279: 43799\u201343804.","DOI":"10.1074\/jbc.M408650200"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Cesare AJ, Reddel RR. Alternative lengthening of telomeres: models, mechanisms and implications. Nature Reviews. Genetics. 2010; 11: 319\u2013330.","DOI":"10.1038\/nrg2763"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Episkopou H, Draskovic I, Van Beneden A, Tilman G, Mattiussi M, Gobin M, et al. Alternative Lengthening of Telomeres is characterized by reduced compaction of telomeric chromatin. Nucleic Acids Research. 2014; 42: 4391\u20134405.","DOI":"10.1093\/nar\/gku114"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Al-Dulaimi S, Matta S, Slijepcevic P, Roberts T. 5-aza-2\u2019-deoxycytidine induces telomere dysfunction in breast cancer cells. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2024; 178: 117173.","DOI":"10.1016\/j.biopha.2024.117173"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Apte MS, Cooper JP. Life and cancer without telomerase: ALT and other strategies for making sure ends (don\u2019t) meet. Critical Reviews in Biochemistry and Molecular Biology. 2017; 52: 57\u201373.","DOI":"10.1080\/10409238.2016.1260090"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Lee JJ, Lee J, Lee H. Alternative paths to telomere elongation. Seminars in Cell & Developmental Biology. 2021; 113: 88\u201396.","DOI":"10.1016\/j.semcdb.2020.11.003"},{"key":"ref12","unstructured":"Yeager TR, Neumann AA, Englezou A, Huschtscha LI, Noble JR, Reddel RR. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Research. 1999; 59: 4175\u20134179."},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Londo\u00f1o-Vallejo JA, Der-Sarkissian H, Cazes L, Bacchetti S, Reddel RR. Alternative lengthening of telomeres is characterized by high rates of telomeric exchange. Cancer Research. 2004; 64: 2324\u20132327.","DOI":"10.1158\/0008-5472.can-03-4035"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Azzalin CM, Reichenbach P, Khoriauli L, Giulotto E, Lingner J. Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science (New York, N.Y.). 2007; 318: 798\u2013801.","DOI":"10.1126\/science.1147182"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Dilley RL, Greenberg RA. ALTernative Telomere Maintenance and Cancer. Trends in Cancer. 2015; 1: 145\u2013156.","DOI":"10.1016\/j.trecan.2015.07.007"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Sobinoff AP, Pickett HA. Alternative Lengthening of Telomeres: DNA Repair Pathways Converge. Trends in Genetics: TIG. 2017; 33: 921\u2013932.","DOI":"10.1016\/j.tig.2017.09.003"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Arora R, Lee Y, Wischnewski H, Brun CM, Schwarz T, Azzalin CM. RNaseH1 regulates TERRA-telomeric DNA hybrids and telomere maintenance in ALT tumour cells. Nature Communications. 2014; 5: 5220.","DOI":"10.1038\/ncomms6220"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Amato R, Valenzuela M, Berardinelli F, Salvati E, Maresca C, Leone S, et al. G-quadruplex Stabilization Fuels the ALT Pathway in ALT-positive Osteosarcoma Cells. Genes. 2020; 11: 304.","DOI":"10.3390\/genes11030304"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Claussin C, Chang M. The many facets of homologous recombination at telomeres. Microbial Cell (Graz, Austria). 2015; 2: 308\u2013321.","DOI":"10.15698\/mic2015.09.224"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Clynes D, Jelinska C, Xella B, Ayyub H, Scott C, Mitson M, et al. Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX. Nature Communications. 2015; 6: 7538.","DOI":"10.1038\/ncomms8538"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Brosnan-Cashman JA, Yuan M, Graham MK, Rizzo AJ, Myers KM, Davis C, et al. ATRX loss induces multiple hallmarks of the alternative lengthening of telomeres (ALT) phenotype in human glioma cell lines in a cell line-specific manner. Plos One. 2018; 13: e0204159.","DOI":"10.1371\/journal.pone.0204159"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Li F, Deng Z, Zhang L, Wu C, Jin Y, Hwang I, et al. ATRX loss induces telomere dysfunction and necessitates induction of alternative lengthening of telomeres during human cell immortalization. The EMBO Journal. 2019; 38: e96659.","DOI":"10.15252\/embj.201796659"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Valenzuela M, Amato R, Sgura A, Antoccia A, Berardinelli F. The Multiple Facets of ATRX Protein. Cancers. 2021; 13: 2211.","DOI":"10.3390\/cancers13092211"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Dran\u00e9 P, Ouararhni K, Depaux A, Shuaib M, Hamiche A. The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3. Genes & Development. 2010; 24: 1253\u20131265.","DOI":"10.1101\/gad.566910"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Lewis PW, Elsaesser SJ, Noh KM, Stadler SC, Allis CD. Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres. Proceedings of the National Academy of Sciences of the United States of America. 2010; 107: 14075\u201314080.","DOI":"10.1073\/pnas.1008850107"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Gaela VM, Hsia HY, Joseph NA, Tzeng WY, Ting PC, Shen YL, et al. Orphan nuclear receptors-induced ALT-associated PML bodies are targets for ALT inhibition. Nucleic Acids Research. 2024; 52: 6472\u20136489.","DOI":"10.1093\/nar\/gkae389"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Clynes D, Jelinska C, Xella B, Ayyub H, Taylor S, Mitson M, et al. ATRX dysfunction induces replication defects in primary mouse cells. Plos One. 2014; 9: e92915.","DOI":"10.1371\/journal.pone.0092915"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Rizzo A, Salvati E, Porru M, D\u2019Angelo C, Stevens MF, D\u2019Incalci M, et al. Stabilization of quadruplex DNA perturbs telomere replication leading to the activation of an ATR-dependent ATM signaling pathway. Nucleic Acids Research. 2009; 37: 5353\u20135364.","DOI":"10.1093\/nar\/gkp582"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Law MJ, Lower KM, Voon HPJ, Hughes JR, Garrick D, Viprakasit V, et al. ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent manner. Cell. 2010; 143: 367\u2013378.","DOI":"10.1016\/j.cell.2010.09.023"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Dharmaiah S, Malgulwar PB, Johnson WE, Chen BA, Sharin V, Whitfield BT, et al. G-quadruplex stabilizer CX-5461 effectively combines with radiotherapy to target \u03b1-thalassemia\/mental retardation X-linked-deficient malignant glioma. Neuro-oncology. 2025; 27: 932\u2013947.","DOI":"10.1093\/neuonc\/noae248"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Min J, Wright WE, Shay JW. Alternative Lengthening of Telomeres Mediated by Mitotic DNA Synthesis Engages Break-Induced Replication Processes. Molecular and Cellular Biology. 2017; 37: e00226-17.","DOI":"10.1128\/MCB.00226-17"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Schwartzentruber J, Korshunov A, Liu XY, Jones DTW, Pfaff E, Jacob K, et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature. 2012; 482: 226\u2013231.","DOI":"10.1038\/nature10833"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Watson LA, Goldberg H, B\u00e9rub\u00e9 NG. Emerging roles of ATRX in cancer. Epigenomics. 2015; 7: 1365\u20131378.","DOI":"10.2217\/epi.15.82"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Cantero D, Mollejo M, Sep\u00falveda JM, D\u2019Haene N, Guti\u00e9rrez-Guam\u00e1n MJ, Rodr\u00edguez de Lope \u00c1, et al. TP53, ATRX alterations, and low tumor mutation load feature IDH-wildtype giant cell glioblastoma despite exceptional ultra-mutated tumors. Neuro-oncology Advances. 2020; 2: vdz059.","DOI":"10.1093\/noajnl\/vdz059"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"MacKenzie D Jr, Watters AK, To JT, Young MW, Muratori J, Wilkoff MH, et al. ALT Positivity in Human Cancers: Prevalence and Clinical Insights. Cancers. 2021; 13: 2384.","DOI":"10.3390\/cancers13102384"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Wang E, Rotondo F, Cusimano MD. Alpha thalassemia\/mental retardation X-linked (ATRX) protein expression in human pituitary neuroendocrine tumours and its reported correlation to prognosis and clinical outcomes: A systematic review. Plos One. 2025; 20: e0313380.","DOI":"10.1371\/journal.pone.0313380"},{"key":"ref37","unstructured":"Linke SP, Sengupta S, Khabie N, Jeffries BA, Buchhop S, Miska S, et al. p53 interacts with hRAD51 and hRAD54, and directly modulates homologous recombination. Cancer Research. 2003; 63: 2596\u20132605."},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Lee S, Cavallo L, Griffith J. Human p53 binds Holliday junctions strongly and facilitates their cleavage. The Journal of Biological Chemistry. 1997; 272: 7532\u20137539.","DOI":"10.1074\/jbc.272.11.7532"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Willers H, McCarthy EE, Alberti W, Dahm-Daphi J, Powell SN. Loss of wild-type p53 function is responsible for upregulated homologous recombination in immortal rodent fibroblasts. International Journal of Radiation Biology. 2000; 76: 1055\u20131062.","DOI":"10.1080\/09553000050111523"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Farooqi AS, Dagg RA, Choi LMR, Shay JW, Reynolds CP, Lau LMS. Alternative lengthening of telomeres in neuroblastoma cell lines is associated with a lack of MYCN genomic amplification and with p53 pathway aberrations. Journal of Neuro-oncology. 2014; 119: 17\u201326.","DOI":"10.1007\/s11060-014-1456-8"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Udroiu I, Marinaccio J, Sgura A. Inhibition of p53 and ATRX increases telomeric recombination in primary fibroblasts. FEBS Open Bio. 2023; 13: 1683\u20131698.","DOI":"10.1002\/2211-5463.13680"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Hartlieb SA, Sieverling L, Nadler-Holly M, Ziehm M, Toprak UH, Herrmann C, et al. Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome. Nature Communications. 2021; 12: 1269.","DOI":"10.1038\/s41467-021-21247-8"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Razak ZRA, Varkonyi RJ, Kulp-McEliece M, Caslini C, Testa JR, Murphy ME, et al. p53 differentially inhibits cell growth depending on the mechanism of telomere maintenance. Molecular and Cellular Biology. 2004; 24: 5967\u20135977.","DOI":"10.1128\/MCB.24.13.5967-5977.2004"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science (New York, N.Y.). 1998; 282: 1497\u20131501.","DOI":"10.1126\/science.282.5393.1497"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Knutsen T, Padilla-Nash HM, Wangsa D, Barenboim-Stapleton L, Camps J, McNeil N, et al. Definitive molecular cytogenetic characterization of 15 colorectal cancer cell lines. Genes, Chromosomes & Cancer. 2010; 49: 204\u2013223.","DOI":"10.1002\/gcc.20730"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nature Protocols. 2006; 1: 1112\u20131116.","DOI":"10.1038\/nprot.2006.179"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Berardinelli F, Siteni S, Tanzarella C, Stevens MF, Sgura A, Antoccia A. The G-quadruplex-stabilising agent RHPS4 induces telomeric dysfunction and enhances radiosensitivity in glioblastoma cells. DNA Repair. 2015; 25: 104\u2013115.","DOI":"10.1016\/j.dnarep.2014.10.009"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Flynn RL, Cox KE, Jeitany M, Wakimoto H, Bryll AR, Ganem NJ, et al. Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors. Science (New York, N.Y.). 2015; 347: 273\u2013277.","DOI":"10.1126\/science.1257216"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Ritchie K, Seah C, Moulin J, Isaac C, Dick F, B\u00e9rub\u00e9 NG. Loss of ATRX leads to chromosome cohesion and congression defects. The Journal of Cell Biology. 2008; 180: 315\u2013324.","DOI":"10.1083\/jcb.200706083"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Berardinelli F, Antoccia A, Cherubini R, De Nadal V, Gerardi S, Cirrone GAP, et al. Transient activation of the ALT pathway in human primary fibroblasts exposed to high-LET radiation. Radiation Research. 2010; 174: 539\u2013549.","DOI":"10.1667\/RR2127.1"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Montero JJ, L\u00f3pez de Silanes I, Gra\u00f1a O, Blasco MA. Telomeric RNAs are essential to maintain telomeres. Nature Communications. 2016; 7: 12534.","DOI":"10.1038\/ncomms12534"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Henson JD, Lau LM, Koch S, Martin La Rotta N, Dagg RA, Reddel RR. The C-Circle Assay for alternative-lengthening-of-telomeres activity. Methods (San Diego, Calif.). 2017; 114: 74\u201384.","DOI":"10.1016\/j.ymeth.2016.08.016"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Salvati E, Leonetti C, Rizzo A, Scarsella M, Mottolese M, Galati R, et al. Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect. The Journal of Clinical Investigation. 2007; 117: 3236\u20133247.","DOI":"10.1172\/JCI32461"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Berardinelli F, Sgura A, Facoetti A, Leone S, Vischioni B, Ciocca M, et al. The G-quadruplex-stabilizing ligand RHPS4 enhances sensitivity of U251MG glioblastoma cells to clinical carbon ion beams. The FEBS Journal. 2018; 285: 1226\u20131236.","DOI":"10.1111\/febs.14415"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Berardinelli F, Coluzzi E, Sgura A, Antoccia A. Targeting telomerase and telomeres to enhance ionizing radiation effects in in vitro and in vivo cancer models. Mutation Research. Reviews in Mutation Research. 2017; 773: 204\u2013219.","DOI":"10.1016\/j.mrrev.2017.02.004"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Zizza P, Cingolani C, Artuso S, Salvati E, Rizzo A, D\u2019Angelo C, et al. Intragenic G-quadruplex structure formed in the human CD133 and its biological and translational relevance. Nucleic Acids Research. 2016; 44: 1579\u20131590.","DOI":"10.1093\/nar\/gkv1122"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Wang Y, Yang J, Wild AT, Wu WH, Shah R, Danussi C, et al. G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma. Nature Communications. 2019; 10: 943.","DOI":"10.1038\/s41467-019-08905-8"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Watson LA, Solomon LA, Li JR, Jiang Y, Edwards M, Shin-ya K, et al. Atrx deficiency induces telomere dysfunction, endocrine defects, and reduced life span. The Journal of Clinical Investigation. 2013; 123: 2049\u20132063.","DOI":"10.1172\/JCI65634"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Pang Y, Cheng M, Wang J, Wang R, Chen X, Zhang C, et al. ATRX cooperates with TOP2B for replication fork stability and DNA damage response through G-quadruplex regulation. Nucleic Acids Research. 2025; 53: gkaf939.","DOI":"10.1093\/nar\/gkaf939"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Akter J, Katai Y, Sultana P, Takenobu H, Haruta M, Sugino RP, et al. Loss of p53 suppresses replication stress-induced DNA damage in ATRX-deficient neuroblastoma. Oncogenesis. 2021; 10: 73.","DOI":"10.1038\/s41389-021-00363-6"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Gulve N, Su C, Deng Z, Soldan SS, Vladimirova O, Wickramasinghe J, et al. DAXX-ATRX regulation of p53 chromatin binding and DNA damage response. Nature Communications. 2022; 13: 5033.","DOI":"10.1038\/s41467-022-32680-8"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Lovejoy CA, Takai K, Huh MS, Picketts DJ, de Lange T. ATRX affects the repair of telomeric DSBs by promoting cohesion and a DAXX-dependent activity. Plos Biology. 2020; 18: e3000594.","DOI":"10.1371\/journal.pbio.3000594"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Aguilera P, L\u00f3pez-Contreras AJ. ATRX, a guardian of chromatin. Trends in Genetics: TIG. 2023; 39: 505\u2013519.","DOI":"10.1016\/j.tig.2023.02.009"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Porro A, Feuerhahn S, Lingner J. TERRA-reinforced association of LSD1 with MRE11 promotes processing of uncapped telomeres. Cell Reports. 2014; 6: 765\u2013776.","DOI":"10.1016\/j.celrep.2014.01.022"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Porro A, Feuerhahn S, Delafontaine J, Riethman H, Rougemont J, Lingner J. Functional characterization of the TERRA transcriptome at damaged telomeres. Nature Communications. 2014; 5: 5379.","DOI":"10.1038\/ncomms6379"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Tutton S, Azzam GA, Stong N, Vladimirova O, Wiedmer A, Monteith JA, et al. Subtelomeric p53 binding prevents accumulation of DNA damage at human telomeres. The EMBO Journal. 2016; 35: 193\u2013207.","DOI":"10.15252\/embj.201490880"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Graham MK, Kim J, Da J, Brosnan-Cashman JA, Rizzo A, Baena Del Valle JA, et al. Functional Loss of ATRX and TERC Activates Alternative Lengthening of Telomeres (ALT) in LAPC4 Prostate Cancer Cells. Molecular Cancer Research: MCR. 2019; 17: 2480\u20132491.","DOI":"10.1158\/1541-7786.MCR-19-0654"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"Geiller HEB, Harvey A, Jones RE, Grimstead JW, Cleal K, Hendrickson EA, et al. ATRX modulates the escape from a telomere crisis. Plos Genetics. 2022; 18: e1010485.","DOI":"10.1371\/journal.pgen.1010485"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"Taylor WR, Stark GR. Regulation of the G2\/M transition by p53. Oncogene. 2001; 20: 1803\u20131815.","DOI":"10.1038\/sj.onc.1204252"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Stark GR, Taylor WR. Control of the G2\/M transition. Molecular Biotechnology. 2006; 32: 227\u2013248.","DOI":"10.1385\/MB:32:3:227"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/9\/10.31083\/FBL52954","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:22:20Z","timestamp":1790698940000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/9\/10.31083\/FBL52954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":70,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2768-6701(26)02272-0"],"URL":"https:\/\/doi.org\/10.31083\/fbl52954","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"article-number":"52954"}}